Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

Table 1 Univariate analysis between survived and deceased patients at 30 d

Variables	Survived (n = 29)	Deceased (n = 23)	P
Demographic
Age (yr)	40 ± 9.6	44 ± 12	0.114
Alcohol consumption per day (g/d)	291 ± 140	302 ± 159	0.809
Male, n (%)	28 (97)	20 (87)	0.222
Laboratory parameters at admission
White blood cell counts (103/μL)	17362 ± 9807	21772 ± 10131	0.11
Glucose (mg/dL)	102 ± 49	102 ± 61	0.987
Sodium (mmol/L)	132 ± 6	128 ± 6	0.019a
Total bilirubin (mg/dL)	17.3 ± 8.9	23.6 ± 9.4	0.018a
AST (IU/L)	172 ± 111	189 ± 93	0.55
ALT (IU/L)	66.9 ± 40.5	71.5 ± 33	0.66
γGT (IU/L)	369 ± 254	291 ± 183	0.282
Alkaline phosphatase (IU/L)	254 ± 109	222 ± 112	0.344
Creatinine (mg/dL)	1.61 ± 1.5	3.5 ± 2.5	0.001a
INR	2.05 ± 0.6	2.49 ± 1.48	0.079
Prothrombin time (s)	23.14 ± 8.1	27.2 ± 11.2	0.142
Albumin (mg/dL)	2.8 ± 0.5	2.5 ± 0.6	0.73
Cholesterol (mg/dL)	150.8 ± 68	116 ± 53	0.081
Triglycerides (mg/dL)	222 ± 122	230 ± 178	0.869
Calcium (mg/dL)	7.9 ± 0.7	7.5 ± 1.1	0.10
Clinical manifestations at admission
Ascites, n (%)	25 (86)	22 (95)	0.468
Child status			0.023a
Grade B, n (%)	6 (20)	0
Grade C, n (%)	23 (80)	23 (100)
Encephalophaty, n (%)			0.335
None	13 (45)	7 (30)
Stage I	4 (14)	5 (22)
Stage II	8 (28)	10 (43)
Stage III	4 (14)	1 (4)
Hepatorenal syndrome, n (%)	5 (17)	14 (61)	0.001a
Severity of liver disease at admission
MELD-Na score	25.5 ± 8	31.9 ± 6	0.003a
Maddrey DFI	69.4 ± 42	93 ± 53.8	0.08
MELD	32.1 ± 6.5	25.1 ± 2.9	0.79

^aP < 0.05 vs survived patients at 30 d. MELD: Model for end-stage liver disease; DFI: Discrimination function index; INR: International normalized ratio; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; γGT: Gamma glutamyl transpeptidase.